[1]
“The impact of COVID-19 infection on botulinum toxin hypersensitivity: Case report and literature review”, J Pak Assoc Dermatol, vol. 33, no. 4, pp. 1762–1766, Oct. 2023, doi: 10.66344/jpad.33.4.2023.2313.